Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-023903
Filing Date
2022-04-08
Accepted
2022-04-08 19:03:08
Documents
1
Period of Report
2022-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 36341
  Complete submission text file 0001209191-22-023903.txt   37849
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address
Gibson Christopher (Reporting) CIK: 0001856369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 22818220